To overcome these constraints and ascertain whether Lp(a) can be reliably incorporated into risk prediction models for stroke prevention in atrial fibrillation, future large-scale, prospective, multi-ethnic studies with harmonized Lp(a) assays and patient-level data will be crucial. The gene discussed is LPA; the disease is Stroke.